Premature ejaculation – definition, classification and therapy. Part II
Abstract
Premature ejaculation (PE) and erectile dysfunction (ED, impotence) are the two main complaints in male sexual medicine. It can affect men at all ages and has a serious impact on the quality of life for men and their partners. Although PE is a very common male sexual dysfunction, it is poorly understood. Patients are often unwilling to discuss their symptoms and many physicians do not know about effective treatments. Therapy should involve the man and his partner (mainly psychotherapy and sexual education). The primary aims of therapy are for the man to extend the intravaginal ejaculation latency time (IELT), to regain a sense of control over his ejaculation time and for him and his partner to feel satisfaction with sexual intercourse. The most effective therapies for PE are: tricyclic antidepressants, certain selective serotonin reuptake inhibitors (SSRI, mainly dapoxetine), serotonin antagonist and reuptake inhibitor (SARI) and phosphodiesterase type 5 inhibitors (PDE-5),given on a daily basis or “on demand” before sexual activity. Topical anaesthetics have also been shown to be effective. The aim of the study is to describe the prevalence, the diagnosis and the classification of the PE. In the second part the main issues which are connected with biological therapy (pharmacotherapy) of the PE were described.
Read the paper
Related studies
- Understanding and treating ejaculatory dysfunction in men with diabetes mellitus
- An Eco-Friendly Solid-State Electrode Modified With ZnO Nanoparticles Decorated With MWCNT as an Electrochemical Sensor for the Determination of Avanafil in Pure Form, Dosage Form and Human Plasma
- Combinations of Freeze-Dried Amorphous Vardenafil Hydrochloride with Saccharides as a Way to Enhance Dissolution Rate and Permeability
- Return to Sport, Reinjury Rate, and Tissue Changes after Muscle Strain Injury: A Narrative Review
- 875: High Prevalence of Significant Comorbid Conditions in Men with Erectile Dysfunction: Momentus Trial Demonstrates Efficacy and Safety of Tadalafil in this Group
- Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.